BOMA ‘Notable Transactions’ panel takes a closer look at some headline-grabbing deals
By John B. Mugford
So far, the year 2021 – a year in which healthcare real estate (HRE) has been elevated to unprecedented heights in the eyes of investors – has undoubtedly produced some notable acquisitions and deals in the medical office building (MOB) sector.
■ the sale of an MOB in California at what just a couple of years ago would’ve been considered an unthinkable capitalization (cap) rate of about 3 percent (as indicated by industry sources);
■ a mid-year, $620.4 million MOB and life science portfolio sale that, at the time, was the largest MOB portfolio deal of the year at $463 million for just the medical office properties; and
■ the formation of a new investment platform that includes one of the sector’s long-time firms and which expects to make $500 million of purchases in the next couple of years.
Executives with the firms involved in the above deals talked in more detail about the transactions during a well-attended panel session at BOMA International’s 2021 Medical Office Building + Healthcare Real Estate Conference held Nov. 1-3 at the Omni Dallas Hotel.
In addition to providing further details and strategies concerning those deals, the panelists also discussed other topics, such as
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE